Recruiting

GlucoTab for Insulin Management in Type 2 Diabetes Patients in Nursing Care

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Diabetes Mellitus+3

+ Diabetes Mellitus, Type 2

+ Endocrine System Diseases

Over 18 Years
+14 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: April 2025
See protocol details

Summary

Principal SponsorMedical University of Graz
Study ContactLichtenegger
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: April 8, 2025

Actual date on which the first participant was enrolled.

This study focuses on a device called GlucoTab, a tool designed to help healthcare professionals manage insulin therapy for patients with diabetes. Specifically, the study looks at how well GlucoTab works for patients with Type 2 diabetes who live in nursing homes or receive nursing care at home and need insulin therapy. The goal is to understand if GlucoTab can improve care for these patients, making insulin management easier and more effective. During the study, participants will use the GlucoTab system to manage their basal insulin therapy. The study will measure how well GlucoTab works by looking at the average percentage of fasting blood glucose levels that fall within the target range of 80 - 180 mg/dl. This range is considered healthy for people with diabetes. The study does not involve any additional invasive or stressful procedures beyond standard care.

Official TitleAn Open, Multicentre, Prospective, Non-interventional Study of the CE-marked Medical Device GlucoTab in Nursing Homes and Domiciliary Nursing Care, According to Intended Use Without Additional Invasive and Stressful Measures
NCT06605859
Principal SponsorMedical University of Graz
Study ContactLichtenegger
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

40 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Diabetes MellitusDiabetes Mellitus, Type 2Endocrine System DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesGlucose Metabolism Disorders

Criteria

5 inclusion criteria required to participate
Elderly people, willing to be treated with a basal insulin therapy according to the GlucoTab system

Informed consent obtained after being advised of the nature of the study

Male or female aged ≥ 18 years

Type 2 diabetes (treated with insulin therapy)

Show More Criteria

9 exclusion criteria prevent from participating
type 1 diabetes mellitus

intravenous insulin therapy

hyperglycaemic episodes (ketoacidosis, hyperosmolar state) if they require intravenous insulin therapy

continuous subcutaneous insulin infusion

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

IDIAP Jordi Gol

Tarragona, SpainOpen IDIAP Jordi Gol in Google Maps
Recruiting
One Study Center
GlucoTab for Insulin Management in Type 2 Diabetes Patients in Nursing Care | PatLynk